• Top 10 Stories Of 2017: CRISPR, Best Practices, And More

    Bio-IT World | As we head into 2018, we at Bio-IT World would like to take a moment and reflect on the groundbreaking achievements from this past year. In that spirit, here are the top 10 stories of 2017.

    Dec 27, 2017

  • Text Mining Life Science Abstracts Vs. Full-Text Articles

    Bio-IT World Contributed Commentary | Because article abstracts are easily accessible through databases, many researchers rely on abstracts for text mining rather than sourcing full-text articles. However, new research from bioinformaticians at the University of Copenhagen and the University of Denmark confirm that essential information remains hidden when only abstracts are mined.

    Dec 20, 2017

  • The First CRISPR Clinical Trial Could Begin in 2018

    Futurism | For the first time ever, a CRISPR clinical trial has been applied for and will hopefully prove that the gene-editing technique truly holds potential.

    Dec 19, 2017

  • Year In Review: 2017 Conferences, Discussions, Awards

    Bio-IT World | A look back at the conferences held by Cambridge Healthtech Institute, covering a wide range of content focusing on bringing members of the biotech, next generation sequencing, IT, and personalized medicine communities to come together to promote innovation at the intersection between biology and technology.

    Dec 19, 2017

  • Engaging The Black Box: How AI Changes The Stakes For Pharma

    Bio-IT World Contributed Commentary | Pharmaceutical and biotechnology companies  are looking to leverage AI to reverse the decline in R&D productivity that has persisted in the face of other IT technologies, such as structure-based drug design or bioinformatics.

    Dec 14, 2017

  • Gamers Help Researchers Tackle The Problem Of Protein Folding

    Bio-IT World | Foldit is an online puzzle video game designed to fold the structures of selected proteins as perfectly as possible. Recently, the developers of the game have been partnering with companies and institutions, including Mars Incorporated and Thermo Fisher Scientific, to help target the issue of carcinogens in food.

    Dec 13, 2017

  • Researchers At Mount Sinai, Sema4 Develop Powerful New Method For Microbiome Analysis

    Bio-IT World Brief | Scientists from the Icahn School of Medicine at Mount Sinai, Sema4, and collaborating institutions New York University and the University of Florida published a report detailing their new, more accurate method for identifying individual microbial species and strains in a community.

    Dec 12, 2017

  • Race And Ancestry: Distinguishing The Two For Genetic Studies

    Bio-IT World | The findings from a study elucidating the differences in molecular alterations in multiple myeloma as a function of self-reported race and genetic ancestry were recently published in PLOS Genetics.

    Dec 11, 2017

  • The Biotech Industry Needs To Pay More Attention To Women's Health

    STAT | In this opinion piece, the authors argue that reversing the dearth of investment in women's health would be good for women, for the biotech industry, and for the U.S. economy.

    Dec 8, 2017

  • Neuroscientists Just Launched an Atlas of the Developing Human Brain

    WIRED | It's a look at how genes are expressed during the earliest stages of life-down to the cellular level.

    Dec 7, 2017

  • The Increasingly Important Role Of Project Manager In Life Sciences

    Bio-IT World Contributed Commentary | Life sciences, like many industries, require skilled, strategic-minded project managers. As a result of this, life science companies must empower PMs with more robust technology that meets unique industry needs.

    Dec 7, 2017

  • Cambridge Biotech Wants Workers To Understand Patients' Diet Experience

    The Boston Globe | Biotech companies developing drugs for rare diseases often invite patients to visit so workers can put a human face on illnesses that could be viewed as abstract scientific puzzles. Akcea Therapeutics is taking that idea further - it wants staffers to get a taste of life with a super-rare metabolic disorder.

    Dec 6, 2017

  • Google Has Released An AI Tool That Makes Sense Of Your Genome

    MIT Technology Review | AI tools could help us turn information gleaned from genetic sequencing into life-saving therapies.

    Dec 5, 2017

  • Medherant, EightSpokes, Cambridge Semantics, And More: News From November 2017

    Bio-IT World | November featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Medherant, EightSpokes, Cambridge Semantics, and more.

    Dec 5, 2017

  • NVIDIA Extends GPU Cloud Support For AI Researchers

    Bio-IT World Brief  NVIDIA has extended NVIDIA GPU Cloud (NGC) support to NVIDIA TITAN, giving AI researchers using desktop GPUs access to NGC. The company has also added new software and other key updates to the NGC container registry to provide researchers a broader, more powerful set of tools to advance their AI and high performance computing research and development efforts.

    Dec 4, 2017

  • Deep Learning In The Clinic: Predicting Patient Prognosis

    Bio-IT World | In a paper published last month on arXiv, and not yet peer-reviewed, Stanford researchers outlined how machine learning can be made to predict prognosis in a clinical setting.

    Dec 4, 2017

  • Edico Genome Launches DRAGEN Complete Suite On AWS Marketplace

    Bio-IT World Brief | During the AWS re:Invent, Edico Genome revealed its DRAGEN Complete Suite on AWS Marketplace, a comprehensive package of pipelines that enables AWS users to access all of DRAGEN's applications for next-generation sequencing data analysis in one click.

    Dec 1, 2017

  • AWS Adds Capabilities For Amazon Aurora And Amazon DynamoDB, Introduces Amazon Neptune

    Bio-IT World Brief | Yesterday at AWS re:Invent, Amazon Web Services (AWS) announced new database capabilities for Amazon Aurora and Amazon DynamoDB, and introduced Amazon Neptune, a new fully managed graph database service.

    Nov 30, 2017

  • A Virus Shortage? BlueBird Bio Buys A Factory To Make Its Own

    Forbes | Amid a reported shortage of the disabled viruses used for gene therapies, BlueBird Bio has purchased a 125,000-square-foot facility in Durham, North Carolina, that it will use for manufacturing the lentiviral vectors used in its treatments.

    Nov 29, 2017

  • AI Exposes Patterns For Faster Drug Discovery

    Bio-IT World Contributed Commentary | Though the results are just starting to emerge, AI is showing positive traction in drug development. Machine learning in particular can help pharma recover the value of repurposed drugs by finding new therapeutic applications for them.

    Nov 29, 2017